ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

CLIA Laboratory Supervisor, Oncology at BillionToOne - ApplyBlast

CLIA Laboratory Supervisor, Oncology

BillionToOne

4 months ago

4.3 on Glassdoor

Menlo Park, CA

Onsite

Full Time

Senior

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

BillionToOne seeks a Clinical Laboratory General Supervisor to oversee high-complexity molecular oncology testing operations within their CLIA-certified laboratory. This leadership role ensures regulatory compliance, quality control, and operational excellence while managing staff and daily workflows during shift operations. The position serves as the primary escalation point for technical issues and partners with technical supervisors to drive continuous improvement in diagnostic testing.

Responsibilities

Provide day-to-day supervision of laboratory personnel during all testing phases
Oversee high-complexity molecular oncology assays and diagnostic testing
Ensure compliance with CLIA and CAP accreditation standards
Review, interpret, and verify test results and quality control data
Lead staff training, onboarding, and competency assessments

Skills

Qualifications

Active California Clinical Laboratory Scientist (CLS) licenseBachelor's degree in Chemical, Biological, Physical, or Clinical Laboratory ScienceMinimum 4 years of clinical laboratory experienceCLIA General Supervisor qualifications under 42 CFR 493.1461Hands-on experience with molecular biology techniques

About BillionToOne

billiontoone.com

Headquarters

Menlo Park, California, United States

Company Size

201-500 employees

Founded

2016

View Profile

BillionToOne is a molecular diagnostics company that develops blood-based tests for prenatal screening and oncology, with a focus on detecting rare genetic variants in cell-free DNA. Its proprietary Quantitative Counting Template technology powers noninvasive prenatal screening and liquid biopsy assays used by healthcare providers and clinical laboratories. The company operates in the genomics and precision diagnostics industry.